首页|佩索利单抗治疗急性泛发性脓疱型银屑病二例并文献复习

佩索利单抗治疗急性泛发性脓疱型银屑病二例并文献复习

扫码查看
报道佩索利单抗治疗 2 例急性泛发性脓疱型银屑病(GPP)的疗效.2 例患者均为男性,均有寻常型银屑病病史,均治疗 1 次(900 mg).治疗前24h的GPP医师总体评估(GPPGA)脓疱评分均为4,GPP皮损面积和严重程度指数(GPPASI)评分分别为 48.0 和 59.3.2 例患者治疗后 48 h GPPGA脓疱单项评分均 0,GPPASI评分改善率为 91.04%和 89.21%.治疗过程中,2 例患者的实验室指标如白细胞计数、中性粒细胞计数及比例、C反应蛋白均在应用佩索利单抗后 48h内逐步回归或接近正常水平,且观察 1 周无反复,体温在给药后 24h内恢复正常且无反复.
Acute generalized pustular psoriasis treated with spesolimab:two cases report and literature review
We report two patients with acute generalized pustular psoriasis(GPP)treated with spesolimab of a single 900 mg intravenous dose.Both patients were male and had a history of psoriasis vulgaris.The pre-treatment generalized pustular psoriasis physician's general assessment(GPPGA)score was 4 in both patients.The scores of generalized pustular psoriasis area and severity index(GPPASI)were 48.0 and 59.3,respec-tively.The GPPGA pustular score of both were 0 at 48 hours after treatment,and the improvement rates of GPPASI were 91.04%and 89.21%,respectively.Laboratory parameters including white blood cell count,neutrophil count,neutrophil ratio,and C-reactive protein returned to or near normal levels within 48 hours af-ter the application of spesolimab,and there was no recurrence during the 1-week observation.Body tempera-ture returned to normal within 24 hours after the administration of spesolimab without recurrence.

acute generalized pustular psoriasisspesolimab

张猛、孙悦鑫、李志瑜、包军、周映

展开 >

南京大学医学院附属鼓楼医院皮肤科,江苏 南京,210008

急性泛发性脓疱型银屑病 佩索利单抗

2025

中国麻风皮肤病杂志
中国麻风防治协会,山东省皮肤病性病防治研究所

中国麻风皮肤病杂志

影响因子:0.302
ISSN:1009-1157
年,卷(期):2025.41(1)